Related Resources

Webinar: Abveris on Lessons Learned from 2+ Years of Discovering Functional Antibodies on the Beacon

At PEGS EU 2021, Abveris CEO Tracey Mullen shared a few important lessons learned through using the Beacon system for antibody discovery. She discussed how the Berkeley Lights Platform has enabled Abveris to focus on deeply screening their antibodies upstream and only pulling forward the most qualified and functionally relevant antibodies for re-expression.

Antibody Discovery

Poster: Rapid Discovery of Therapeutic Antibodies for SARS-CoV-2

Find out how B Cell Antibody Discovery on the Beacon system can be used to rapidly screen human B cell to discover antibodies against difficult targets such as viruses.

Antibody Discovery

Customer Spotlight: Genovac on Antibody Discovery

Find out how Genovac is delivering 10-fold more lead candidates against difficult targets.